GPS clinical intervention for Dementia

GMF Abénakis, Saint-Georges, Canada
DementiaGPS clinical intervention - Other
All Sexes
What conditions do you have?

Study Summary

This trial tests a care model that aims to reduce polymedication and inappropriate medications for seniors undergoing cognitive assessment or suffering from major neurocognitive disorder, while maintaining their cognitive health, quality of life, and autonomy.

Eligible Conditions
  • Dementia

Treatment Effectiveness

Study Objectives

1 Primary · 1 Secondary · Reporting Duration: 12 months prior to the start of the intervention and in the 12 months afterwards

Month 12
Change in number of emergency room visits
Change in number of hospitalizations
Month 6
Change in quality of life
Change in treatment burden
Month 6
Change in number of prescribed medications

Trial Safety

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

2 Treatment Groups

Non exposed FMGs to GPS intervention
1 of 2
Exposed FMGs to GPS intervention
1 of 2

Active Control

Experimental Treatment

400 Total Participants · 2 Treatment Groups

Primary Treatment: GPS clinical intervention · No Placebo Group · N/A

Exposed FMGs to GPS intervention
Experimental Group · 1 Intervention: GPS clinical intervention · Intervention Types: Other
Non exposed FMGs to GPS interventionNoIntervention Group · 1 Intervention: Non exposed FMGs to GPS intervention · Intervention Types:

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 12 months prior to the start of the intervention and in the 12 months afterwards

Who is running the clinical trial?

CHU de Quebec-Universite LavalLead Sponsor
158 Previous Clinical Trials
103,419 Total Patients Enrolled
1 Trials studying Dementia
44 Patients Enrolled for Dementia
CIUSSS du Nord-de-l'Île-de-MontréalUNKNOWN
2 Previous Clinical Trials
272 Total Patients Enrolled
Fonds de la Recherche en Santé du QuébecOTHER_GOV
71 Previous Clinical Trials
44,384 Total Patients Enrolled
2 Trials studying Dementia
82 Patients Enrolled for Dementia
CISSS de Chaudière-AppalachesOTHER_GOV
6 Previous Clinical Trials
15,279 Total Patients Enrolled
Line Guénette, Ph.DStudy DirectorCHU de Québec-Université Laval, Laval University

Eligibility Criteria

Age 65+ · All Participants · 2 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have been referred to a clinic that specializes in memory-related issues.
If you are taking prescription medication, the pharmacist may need to speak with you.

Frequently Asked Questions

How many participants are enrolled in this research endeavor?

"Affirmative. has the latest updates on this ongoing medical trial, first posted in September 2021 and last modified in January 2022. The study is currently enrolling 400 patients from 2 different healthcare facilities." - Anonymous Online Contributor

Unverified Answer

Are there any open opportunities for participants in this clinical trial?

"Affirmative. According to information on, this medical trial that was initially announced on September 27th 2021 is still actively recruiting patients. A total of 400 individuals are sought from two separate medical facilities." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.